Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$49.62 - $58.13 $4,565 - $5,347
-92 Reduced 52.27%
84 $5,000
Q1 2022

May 11, 2022

BUY
$48.27 - $65.25 $3,861 - $5,220
80 Added 83.33%
176 $10,000
Q4 2021

Jan 10, 2022

SELL
$59.5 - $67.25 $1,844 - $2,084
-31 Reduced 24.41%
96 $6,000
Q2 2021

Jul 30, 2021

BUY
$62.12 - $74.2 $1,925 - $2,300
31 Added 32.29%
127 $9,000
Q3 2020

Oct 21, 2020

BUY
$51.39 - $72.41 $1,027 - $1,448
20 Added 26.32%
96 $7,000
Q2 2020

Jul 10, 2020

SELL
$39.55 - $54.65 $197 - $273
-5 Reduced 6.17%
76 $4,000
Q1 2020

Apr 15, 2020

BUY
$34.75 - $45.85 $2,814 - $3,713
81 New
81 $3,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.6B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.